PRX-07034

From Wikipedia, the free encyclopedia
Jump to: navigation, search
PRX-07034
PRX-07034 structure.png
Systematic (IUPAC) name
N-[1-(5-chloro-2,3-dimethoxyphenyl)ethyl]-2-methylsulfonyl-5-piperazin-1-ylaniline
Clinical data
Legal status Uncontrolled
Routes Oral
Identifiers
CAS number ?
ATC code None
PubChem CID 11532574
Chemical data
Formula C21H29Cl2N3O4S 
Mol. mass 490.44 g/mol
 YesY (what is this?)  (verify)

PRX-07034 is a selective 5-HT6 receptor antagonist.[1] It has cognition and memory-enhancing properties and potently decreases food intake and body weight in rodents.[1][2][3][4] PRX-07034 was under development by Epix Pharmaceuticals for the treatment of obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia but upon the company collapsing due to lack of funds the compound was auctioned to another corporation.[5][6][6][7]

References[edit]

External links[edit]